Health
SARS-CoV-2 Neucleocapside (N) protein is heavily glycosylated – News-Medical.Net
However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint server bioRxiv in August 2020 reveals the structure of this protein, a val…
Eight months into the COVID-19 pandemic, there is still no fully protective therapy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has infected millions worldwide. Vaccines are being worked on in a host of institutions and countries, mostly targeting the spike protein of the virus. However, the nucleocapsid (N) protein is also extremely abundant and, therefore, a useful target for both vaccine and diagnostic test development. A new study published on the preprint s…
-
Noosa News20 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business21 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Business19 hours agoEverything you need to know about the Coles dividend
-
Noosa News16 hours agoQueensland man sentenced to four years imprisonment after string of terror offences